Related Experiment Video
Updated: Jun 29, 2025

Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
Upregulation of ESPL1 is associated with poor prognostic outcomes in endometrial cancer
Yuzhong Yang1, Ying Sheng2, Jinhua Zheng1
1Department of Pathology, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.
Background:
Extra spindle pole bodies-like 1 (ESPL1) is known to play a crucial role in the segregation of sister chromatids during mitosis. Overexpression of ESPL1 is considered to have oncogenic effects in various human cancers. However, the specific biological function of ESPL1 in endometrial cancer (EC) remains unclear.
Methods:
The TCGA and GEO databases were utilized to assess the expression of ESPL1 in EC. Immunohistochemistry was utilized to detect separase expression in EC samples. Kaplan-Meier survival analysis and Cox regression analysis were performed to evaluate the diagnostic and prognostic significance of ESPL1 in EC. Gene Set Enrichment Analysis (GSEA) was employed to explore the potential signaling pathway of ESPL1 in EC. Cell proliferation and colony formation ability were analyzed using CCK-8 and colony formation assay.
Results:
Our analysis revealed that ESPL1 is significantly upregulated in EC, and its overexpression is associated with advanced clinical characteristics and unfavourable prognostic outcomes. Suppression of ESPL1 attenuated proliferation of EC cell line.
Conclusion:
The upregulation of ESPL1 is associated with advanced disease and poor prognosis in EC patients. These findings suggest that ESPL1 has the potential to serve as a diagnostic and prognostic biomarker in EC, highlighting its significance in the management of EC patients.
Related Concept Videos
Regulation of the Unfolded Protein Response
Non-LTR Retrotransposons
Abnormal Proliferation
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Maintenance of the ES Cell State
Regulation of Angiogenesis and Blood Supply

